The hypercalcemia of malignancy: Pathogenesis and management
- 1 December 1982
- journal article
- review article
- Published by Elsevier BV in Metabolism
- Vol. 31 (12), 1247-1277
- https://doi.org/10.1016/0026-0495(82)90012-9
Abstract
No abstract availableKeywords
This publication has 172 references indexed in Scilit:
- Biochemical Evaluation of Patients with Cancer-Associated HypercalcemiaNew England Journal of Medicine, 1980
- Specific binding of 1,25 dihydroxyvitamin D3 in the VX2 carcinomaBiochemical and Biophysical Research Communications, 1980
- 1,25-dihydroxyvitamin D3 receptor in a cultured human breast cancer cell line (MCF 7 cells)Biochemical and Biophysical Research Communications, 1980
- Primary HyperparathyroidismNew England Journal of Medicine, 1980
- Purification of a lymphokine: Osteoclast activating factor from human tonsil lymphocytesBiochemical and Biophysical Research Communications, 1978
- Rat osteogenic sarcoma cells: Comparison of the effects of prostaglandins E1, E2, I2 (prostacyclin), 6-keto F1α and thromboxane B2 on cyclic AMP production and adenylate cyclase activityBiochemical and Biophysical Research Communications, 1978
- Effects of hydrocortisone on the hypercalcemia and plasma levels of 13,14-dihydro-15-keto-prostaglandin E2 in mice bearing the HSDM1 fibrosarcomaBiochemical and Biophysical Research Communications, 1977
- Drugs for Disorders of BoneDrugs, 1974
- Parathyroid hormone production and malignancy.BMJ, 1972
- Experiences in the treatment of Paget's disease of bone with mithramycinPublished by American Medical Association (AMA) ,1970